About us

We are a macrophage cell therapy company focused on resolving chronic inflammatory damage. Our multidisciplinary team brings together a diverse set of skills to pursue our mission.

We are a macrophage cell therapy company

Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by Syncona.

Our Focus

Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available. For patients with end-stage liver disease (cirrhosis) the only therapeutic option is liver transplantation, a complex surgical procedure limited by complications and a shortage of donors. At Resolution Therapeutics (RTx), we are developing a macrophage cell therapy product to treat patients at risk of liver decompensation, thus helping them avoid the need for a liver transplant.

Management Team

Picture of Alex Armesilla
Alex Armesilla
Director - Cell Engineering
Picture of Lara Campana
Lara Campana
Director - Macrophage Biology
Picture of Gonzalo Garcia
Gonzalo Garcia
Chief of Staff
Picture of Edward Hodgkin
Edward Hodgkin
Chairman & CEO
Picture of Evelien Stalmeijer
Evelien Stalmeijer
Vice President - Translation
Picture of Philip Starkey Lewis
Philip Starkey Lewis
Director - Pharmacology

The Founders

Picture of Prof. Stuart Forbes
Prof. Stuart Forbes
Prof. of Transplantation & Regenerative Medicine - University of Edinburgh
Picture of Prof. John Campbell
Prof. John Campbell
Director - TCAT Scottish National Blood Transfusion Service

The Board of Directors

Picture of Edward Hodgkin
Edward Hodgkin
Chairman & CEO - Resolution Therapeutics
Picture of Lisa Bright
Lisa Bright
Non-Executive Director
Picture of Martin Murphy
Martin Murphy
Chief Executive Officer - Syncona
Picture of Prof. Stuart Forbes
Prof. Stuart Forbes
Prof. of Transplantation & Regenerative Medicine - University of Edinburgh
Picture of Gonzalo Garcia
Gonzalo Garcia
Chief of Staff - Resolution Therapeutics (Observer)
Picture of Simon Durrant
Simon Durrant
Investment Executive - Old College Capital, University of Edinburgh (Observer)

Our Principles

At RTx we believe that it is important to be deliberate about company culture. Our core company values have been defined with the help of everyone at RTx at all seniority levels. They are an integral part of RTx life, from the hiring process to the running of day-to-day business, and they outline our collective beliefs, thoughts, and feelings and state how we can work together in a fair, inclusive, and effective manner.

 

Our principles are:

  1. 1. We are passionate about delivering scientific excellence for the benefit of patients.
  2. 2. We work together across the whole company from the bottom-up as well as from the top-down to create a One-Team feeling.
  3. 3. We collaborate to create an inclusive and fair environment in RTx.
  4. 4. We encourage transparency and incorporate learning in all we do.
  5. 5. We enjoy the journey by introducing fun in the day-to-day affairs of science and business.

 

More details can be found here.